InsiderClue
Stocks · Health care · Pharmaceutical Preparations

CorMedix Inc.

CRMD Clue Score73
United States Fiscal year ends December CIK 0001410098 Results filed 2 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

13
Insider
Date
Role
Action
Shares
Price
Amount
Alan W Dunton
30 Dec 2025
Director
Sold after exercise
20,000
$13.00
$260.00K
Joseph Todisco
18 Dec 2025
Chief Executive Officer
Sold after exercise
30,000
$12.00
$360.00K
Janet Dillione
9 Dec 2025
Director
Sold after exercise
34,000
$12.00
$408.00K
Janet Dillione
2 Dec 2025
Director
Sold after exercise
46,657
$10.00
$466.57K
Janet Dillione
24 Nov 2025
Director
Sold after exercise
26,343
$9.93
$261.59K
Joseph Todisco
12 Sep 2025
Chief Executive Officer
Sold after exercise
50,000
$13.00
$650.00K
Alan W Dunton
12 Sep 2025
Director
Sold after exercise
10,000
$13.13
$131.30K
Elizabeth Hurlburt
11 Sep 2025
Chief Operating Officer
Sold after exercise
41,121
$13.08
$537.86K
Elizabeth Hurlburt
9 Sep 2025
Chief Operating Officer
Sold after exercise
12,876
$13.51
$173.95K
Kaufman Beth Zelnick
9 Sep 2025
Chief Legal Officer
Sold after exercise
400
$12.82
$5.13K
Kaufman Beth Zelnick
9 Sep 2025
Chief Legal Officer
Sold after exercise
49,600
$13.41
$665.14K
Elizabeth Hurlburt
14 Nov 2024
EVP
Sold after exercise
140,027
$11.18
$1.57M
Antony Pfaffle
7 Feb 2017
Chief Scientific Officer
Sold after exercise
10,000
$2.00
$20.00K
Show all 118 transactions →

What was left out

Form 4 filings counted 271
Amendments (4/A) skipped 20
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 13
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 5,135,252
Sales filed before the plan box existed 1
History held since 1 Apr 2010